Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction

Abstract Aims Spironolactone has been shown to improve outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). We investigated whether the discharge use of spironolactone could be associated with better long‐term outcomes among patients with HF with mid‐range EF (HFmrEF). M...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nobuyuki Enzan, Shouji Matsushima, Tomomi Ide, Hidetaka Kaku, Taiki Higo, Miyuki Tsuchihashi‐Makaya, Hiroyuki Tsutsui
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Oxford University Press 2020-02-01
coleção:	ESC Heart Failure
Assuntos:	Spironolactone Heart failure with mid‐range ejection fraction Outcomes Rehospitalization
Acesso em linha:	https://doi.org/10.1002/ehf2.12571
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!